glutamine has been researched along with Psychotic Disorders in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (14.29) | 29.6817 |
| 2010's | 17 (48.57) | 24.3611 |
| 2020's | 10 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Bissonnette, JN; Crocker, CE; Fisher, DJ; Francis, AM; MacNeil, S; Tibbo, PG | 1 |
| Barbier, EL; Cash, D; Davies, C; Di Censo, D; Hirschler, L; Kiemes, A; Kim, E; Lythgoe, DJ; Modinos, G; Petrinovic, MM; Randall, K; Rojo Gonzalez, L; Rotaru, D; Serrano Navacerrada, ME; Simmons, C; Stone, JM; Vernon, AC | 1 |
| Barker, PB; Cascella, NG; Coughlin, JM; Geman, D; Kelly, A; Nestadt, G; Nucifora, FC; Palaniyappan, L; Sawa, A; Sedlak, TW; Wang, M; Yang, K; Younes, L | 1 |
| Bagautdinova, J; Delavari, F; Eliez, S; Mancini, V; Saleh, MG | 1 |
| Garip, B; Kayir, H | 1 |
| Daly, E; Gudbrandsen, M; Hathway, P; Howes, O; Jauhar, S; McCutcheon, RA; Rogdaki, M | 1 |
| Bojesen, KB; Broberg, BV; Edden, RAE; Fagerlund, B; Glenthøj, BY; Glenthøj, LB; Hjorthøj, C; Krakauer, K; Kristensen, TD; Nordentoft, M; Rostrup, E; Schwartz, C; Wenneberg, C | 1 |
| Benyamina, A; Martelli, C; Petillion, A; Romeo, B | 1 |
| Roalf, DR; Sydnor, VJ | 1 |
| Andersen, GS; Bojesen, KB; Broberg, BV; Edden, RAE; Fagerlund, B; Glenthøj, BY; Jessen, K; Larsson, HBW; Nielsen, MØ; Rostrup, E; Sigvard, A; Tangmose, K; Thomas, MB | 1 |
| Corsi-Zuelli, F; da Roza, DL; Del-Ben, CM; Deminice, R; Fachim, HA; Jordão, AA; Loureiro, CM; Louzada-Junior, P; Menezes, PR; Shuhama, R; Simões-Ambrosio, LMC | 1 |
| Angelescu, I; Cowen, PJ; Emir, U; Godlewska, BR; Howes, O; Lennox, B; Micunovic, M; Minichino, A | 1 |
| Fujita, Y; Hashimoto, K; Iyo, M; Kanahara, N; Nakata, Y; Niitsu, T; Oda, Y; Oishi, K; Shirayama, Y; Takase, M | 1 |
| Carlson, M; Carter, CS; Choo, TH; Corlett, PR; Girgis, RR; Grinband, J; Javitt, DC; Kantrowitz, JT; Kegeles, LS; Krystal, JH; Lesh, TA; Lieberman, JA; Maddock, RJ; Mason, G; Potter, WZ; Qiu, M; Ragland, JD; Robinson, J; Rothman, DL; Tanase, C; Wall, MM | 1 |
| Barker, PB; Coughlin, JM; Crawford, JL; DuBois, SL; Nestadt, G; Nucifora, FC; Nucifora, LG; Pradhan, S; Sawa, A; Schretlen, DJ; Sedlak, TW; Trivedi, A; Wang, AM | 1 |
| Allen, P; Cappucciati, M; Davies, C; De Micheli, A; Fusar-Poli, P; Lythgoe, DJ; McGuire, P; Morrison, P; Murguia, S; Oliver, D; Paloyelis, Y; Provenzani, U; Ramella-Cravaro, V; Rutigliano, G; Scutt, E; Shergill, S; Stone, JM; Taylor, D; Williams, S; Zelaya, F | 1 |
| Abe, O; Aoki, Y; Gonoi, W; Inoue, H; Iwashiro, N; Kasai, K; Katsura, M; Koike, S; Natsubori, T; Sasaki, H; Takano, Y; Takao, H; Yahata, N; Yamasue, H | 1 |
| Fam, J; Furby, H; Howes, OD; Hughes, E; Morgan, C; Pepper, F; Stone, JM | 1 |
| Howells, FM; Meintjes, E; Sinclair, H; Stein, DJ; Temmingh, H; Uhlmann, A; Wilson, D | 1 |
| Chatterjee, M; Dwivedi, AK; Kumari, R; Palit, G; Singh, S; Verma, AK; Verma, R | 1 |
| Akhadov, TA; Dmitrienko, DM; Kaleda, VG; Kanonovich, PS; Lebedeva, IS; Omelchenko, MA; Semenova, NA; Shendyapina, MV; Simonova, OA; Ublinsky, MV | 1 |
| Bakker, JA; Curfs, LM; de Koning, M; Drukker, M; Evers, LJ; van Amelsvoort, TA | 1 |
| Chavez, S; de la Fuente-Sandoval, C; Gómez-Cruz, G; Graff-Guerrero, A; León-Ortiz, P; Plitman, E; Reyes-Madrigal, F | 1 |
| Kraguljac, NV; Lahti, AC; Reid, MA; White, DM | 1 |
| Aleman, A; Bais, L; de Vos, A; Dlabac-De Lange, J; Knegtering, H; Liemburg, E; Opmeer, E; Pijnenborg, G; Sibeijn-Kuiper, A; van der Velde, J; Wunderink, L | 1 |
| Barker, PB; Brandt, AS; Churchill, G; Edden, RA; Harris, AD; Hua, J; Lim, IA; Margolis, RL; Pradhan, S; Ross, CA; Unschuld, PG; van Zijl, PC | 1 |
| HARRIS, MM; HARRIS, RS; ROTH, RT | 1 |
| Desbonnet, L; O'Tuathaigh, CM; Waddington, JL | 1 |
| Kalkman, HO; Loetscher, E | 1 |
| ASTRUP, P; MUNKVAD, I | 1 |
| Balcar, VJ; Nanitsos, EK; Nguyen, KT; St'astný, F | 1 |
| da Silva, AL; Dall'Igna, OP; Hoffmann, A; Lara, DR; Souza, DO | 1 |
| Amminger, GP; Berger, GE; Jackson, GD; McConchie, M; McGorry, PD; Pantelis, C; Proffitt, TM; Velakoulis, D; Wellard, RM; Wood, SJ | 1 |
| Atack, JR; Boggs, JD; Bonaventure, P; Galici, R; Miller, KL | 1 |
| Haas, E | 1 |
6 review(s) available for glutamine and Psychotic Disorders
| Article | Year |
|---|---|
Glutamate and N-Acetylaspartate Alterations Observed in Early Phase Psychosis: A Systematic Review of Proton Magnetic Resonance Spectroscopy Studies.
Topics: Aspartic Acid; Female; Glutamic Acid; Glutamine; Humans; Male; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders | 2022 |
Magnetic resonance spectroscopy studies in subjects with high risk for psychosis: A meta-analysis and review.
Topics: Aspartic Acid; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Schizophrenia | 2020 |
A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk.
Topics: Adolescent; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glutathione; Humans; Psychotic Disorders | 2020 |
Mutant mouse models in evaluating novel approaches to antipsychotic treatment.
Topics: Animals; Antipsychotic Agents; Carrier Proteins; Disease Models, Animal; Dopamine; Dysbindin; Dystrophin-Associated Proteins; Glutamine; Mice; Nerve Tissue Proteins; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synaptic Transmission | 2012 |
GAD(67): the link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis.
Topics: Animals; Brain; Dopamine; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamine; Humans; Isoenzymes; Neurons; Psychotic Disorders; Receptors, AMPA; Receptors, GABA; Receptors, N-Methyl-D-Aspartate | 2003 |
Glutamatergic hypothesis of schizophrenia: involvement of Na+/K+-dependent glutamate transport.
Topics: Animals; Biological Transport; Central Nervous System; Gene Expression Regulation, Enzymologic; Glutamate Plasma Membrane Transport Proteins; Glutamates; Glutamic Acid; Glutamine; Humans; Models, Biological; Neurotransmitter Agents; Prefrontal Cortex; Psychotic Disorders; Schizophrenia; Sodium-Potassium-Exchanging ATPase; Synapses | 2005 |
2 trial(s) available for glutamine and Psychotic Disorders
| Article | Year |
|---|---|
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial.
Topics: Adult; Antipsychotic Agents; Biomarkers; Brain; Drug Development; Female; Glutamic Acid; Glutamine; Humans; Ketamine; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Targeted Therapy; Neuroimaging; Oxygen; Psychotic Disorders; Receptors, Glutamate; Schizophrenia; Young Adult | 2018 |
Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study.
Topics: Adolescent; Adult; Brain; Brain Chemistry; Brain Mapping; Dietary Supplements; Double-Blind Method; Eicosapentaenoic Acid; Female; Glutamic Acid; Glutamine; Glutathione; Humans; Magnetic Resonance Spectroscopy; Male; Oxidative Stress; Placebos; Psychotic Disorders; Temporal Lobe; Time Factors; Treatment Outcome; Up-Regulation | 2008 |
27 other study(ies) available for glutamine and Psychotic Disorders
| Article | Year |
|---|---|
Erbb4 Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging Phenotypes.
Topics: Animals; Glutamine; Hippocampus; Interneurons; Mice; Neuroimaging; Parvalbumins; Phenotype; Psychotic Disorders; Receptor, ErbB-4 | 2023 |
Longitudinal changes in brain metabolites in healthy controls and patients with first episode psychosis: a 7-Tesla MRS study.
Topics: Adult; Aspartic Acid; Brain; Glutamic Acid; Glutamine; Glutathione; Gyrus Cinguli; Humans; Psychotic Disorders; Young Adult | 2023 |
Excitatory/Inhibitory Imbalance Underlies Hippocampal Atrophy in Individuals With 22q11.2 Deletion Syndrome With Psychotic Symptoms.
Topics: Atrophy; DiGeorge Syndrome; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Hippocampus; Humans; Neurodegenerative Diseases; Psychotic Disorders | 2023 |
Alteration in NMDAR-related amino acids in first episode psychosis.
Topics: Asparagine; Chromatography, Liquid; Female; Glutamic Acid; Glutamine; Humans; Hydroxyproline; Male; Mass Spectrometry; Proline; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Serine; Young Adult | 2019 |
Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletion.
Topics: Adolescent; Adult; Corpus Striatum; Cross-Sectional Studies; DiGeorge Syndrome; Female; Genetic Predisposition to Disease; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Psychotic Disorders; Risk Factors; Thalamus; Young Adult | 2019 |
Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition.
Topics: Cognition; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Psychotic Disorders | 2020 |
Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis.
Topics: Antipsychotic Agents; Cognition; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Psychotic Disorders; Schizophrenia | 2021 |
Plasma amino acids profile in first-episode psychosis, unaffected siblings and community-based controls.
Topics: Adult; Amino Acids; Antipsychotic Agents; Body Mass Index; Case-Control Studies; Cross-Sectional Studies; Female; gamma-Aminobutyric Acid; Gas Chromatography-Mass Spectrometry; Glutamic Acid; Glutamine; Glycine; Humans; Linear Models; Male; Proline; Psychotic Disorders; Siblings; Tryptophan; Young Adult | 2020 |
Brain glutamate concentration in men with early psychosis: a magnetic resonance spectroscopy case-control study at 7 T.
Topics: Brain; Case-Control Studies; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders | 2021 |
Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats.
Topics: Animals; Antipsychotic Agents; Brain; Dopamine; Glutamate Decarboxylase; Glutamic Acid; Glutamine; Haloperidol; Infusion Pumps, Implantable; Male; Psychotic Disorders; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Serine | 2017 |
Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis.
Topics: Aspartic Acid; Brain; Case-Control Studies; Cross-Sectional Studies; Dipeptides; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Male; Neuropsychological Tests; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Young Adult | 2019 |
Neurochemical effects of oxytocin in people at clinical high risk for psychosis.
Topics: Administration, Intranasal; Adolescent; Adult; Brain Chemistry; Cross-Over Studies; Double-Blind Method; Glutamic Acid; Glutamine; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Oxytocin; Psychotic Disorders; Risk Factors; Thalamus; Young Adult | 2019 |
Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Topics: Adolescent; Adult; Aspartic Acid; Chronic Disease; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prefrontal Cortex; Prodromal Symptoms; Psychotic Disorders; Risk; Schizophrenia; Young Adult | 2014 |
Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users.
Topics: Adult; Aspartic Acid; Brain; Female; Glutamic Acid; Glutamine; Humans; Ketamine; Magnetic Resonance Spectroscopy; Male; Psychotic Disorders; Substance-Related Disorders; Young Adult | 2014 |
(1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Choline; Creatine; Female; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Methamphetamine; Prefrontal Cortex; Protons; Psychotic Disorders; Substance-Related Disorders; Young Adult | 2014 |
Antipsychotic activity of standardized Bacopa extract against ketamine-induced experimental psychosis in mice: Evidence for the involvement of dopaminergic, serotonergic, and cholinergic systems.
Topics: Animals; Antipsychotic Agents; Bacopa; Dopamine; Dose-Response Relationship, Drug; Glutamine; Ketamine; Male; Mice; Plant Extracts; Psychotic Disorders; Serotonin | 2015 |
[Information processing and brain metabolic characteristics in patients at ultra-high risk for endogenous psychosis].
Topics: Adolescent; Adult; Aspartic Acid; Brain; Choline; Evoked Potentials; Female; Glutamic Acid; Glutamine; Humans; Male; Mental Processes; Neuroimaging; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Risk; Thalamus; Young Adult | 2015 |
Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome.
Topics: 22q11 Deletion Syndrome; Adolescent; Adult; Age Factors; Biomarkers; Cognition; Female; Glutamic Acid; Glutamine; Humans; Intelligence; Intelligence Tests; Longitudinal Studies; Male; Middle Aged; Proline; Psychotic Disorders; Regression Analysis; Young Adult | 2015 |
Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Topics: Adult; Aspartic Acid; Choline; Corpus Striatum; Glutamic Acid; Glutamine; Humans; Inositol; Neuroglia; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Schizophrenia | 2016 |
A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aspartic Acid; Creatine; Diffusion Tensor Imaging; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Multimodal Imaging; Myelin Sheath; Psychotic Disorders; Schizophrenia; White Matter | 2016 |
Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study.
Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Aspartic Acid; Case-Control Studies; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Male; Middle Aged; Neurotransmitter Agents; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Regression Analysis; Risk; Severity of Illness Index; Time Factors | 2016 |
Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.
Topics: Adult; Aging; Antipsychotic Agents; Aspartic Acid; Choline; Creatine; Dipeptides; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glutathione; Gyrus Cinguli; Humans; Inositol; Male; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Schizophrenia | 2016 |
Studies regarding glutamine and ammonia in the cerebrospinal fluid of patients with nervous and mental diseases (with some observations on insulin hypoglycemic shock and oligophrenia phenylpyruvica).
Topics: Ammonia; Cerebrospinal Fluid; Glutamine; Humans; Hypoglycemic Agents; Insulin; Intellectual Disability; Mental Disorders; Nervous System Diseases; Neurotic Disorders; Phenylketonurias; Psychopathology; Psychotic Disorders | 1945 |
[Glutamine and glutamic acid metabolism, with special reference to nervous tissue and psychiatric disease].
Topics: Glutamic Acid; Glutamine; Humans; Nerve Tissue; Psychotic Disorders; Schizophrenia | 1951 |
Beta-amyloid treatment sensitizes mice to amphetamine-induced locomotion but reduces response to caffeine.
Topics: Adenosine; Adrenergic Agents; Alzheimer Disease; Amphetamine; Amyloid beta-Peptides; Animals; Avoidance Learning; Brain; Caffeine; Central Nervous System Stimulants; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Glutamine; Injections, Intraventricular; Male; Mice; Motor Activity; Psychotic Disorders | 2004 |
Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
Topics: Amphetamine; Animals; Antipsychotic Agents; Arousal; Brain; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glutamine; Injections, Intraperitoneal; Injections, Subcutaneous; Ketamine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phenols; Psychotic Disorders; Receptors, Serotonin; Reflex, Startle; Sulfonamides; Synaptic Transmission | 2008 |
[Restoration of subjective equilibrium in clinical experimentation (evaluation of new drugs used in psychosomatic medicine)].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Glutamine; Humans; Male; Middle Aged; Neurotic Disorders; Postural Balance; Psychotic Disorders; Pyrimidines; Sulfanilamides; Vitamins | 1968 |